Solventum Corp | SOLV - Gross Profit On Sales


Solventum Corp reported $1.14B in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Abbott USD 6.54B 625M Dec/2025
Align Technology USD 683.59M 44.39M Dec/2025
Baxter International USD 577M 373M Dec/2025
Becton, Dickinson and Co. USD 2.41B 1.72B Dec/2025
Cencora USD 2.96B 48.98M Sep/2025
Dexcom USD 792.7M 61.3M Dec/2025
Insulet USD 568.6M 58.5M Dec/2025
Solventum Corp USD 1.14B 40M Sep/2025
West Pharmaceutical Services USD 303.9M 9.6M Dec/2025
Zimmer Biomet Holdings USD 1.27B 8.1M Dec/2025